Robotics & Automation News

Where Innovation Meets Imagination

cancer

Abu Dhabi connects with clinic in America to perform ‘first transcontinental’ robotic assisted cancer operation

by

Cleveland Clinic Abu Dhabi, part of the M42 group, has achieved a historic milestone in global healthcare.

In collaboration with experts from Cleveland Clinic in the US, the team performed the world’s first remotely conducted transcontinental robotic-assisted focal therapy for prostate cancer.

Focal therapy is a non-invasive treatment that precisely targets a specific section of the prostate using ultrasound beams, eliminating the need for major surgery or radiation. The Focal-One system enhances this approach with a robotic arm that ensures precise and controlled ultrasound delivery. [Read more…] about Abu Dhabi connects with clinic in America to perform ‘first transcontinental’ robotic assisted cancer operation

EDAP and Avenda Health launch ‘world’s first’ robotic ultrasound cancer surgery system

by

EDAP, a specialist developer of robotic energy-based therapies, and Avenda Health, an AI healthcare company, have agreed a collaboration agreement for the purpose of offering personalized prostate cancer care.

The two companies will utilize Avenda’s AI technology, Unfold AI, to launch “the world’s first AI-assisted Focal One robotic high-intensity focused ultrasound (HIFU) procedures”.

Avenda Health’s Unfold AI is a multimodal AI decision support platform cleared by the US Food and Drug Administration (FDA) that brings “superhuman” abilities to cancer surgeons and oncologists to power the future of cancer care. [Read more…] about EDAP and Avenda Health launch ‘world’s first’ robotic ultrasound cancer surgery system

Medical Advancements in 2024: A Leap Forward for Women’s Health

by

In 2024, the landscape of women’s health is witnessing revolutionary changes due to significant medical advancements.

These innovations are not only transforming diagnostic and treatment processes but are also making healthcare more personalized and accessible to women globally.

With the enhancement of cancer screening techniques, the introduction of targeted therapies, and the expansion of reproductive and mental health services, the focus has intensely shifted towards ensuring timely and more efficient patient care.

[Read more…] about Medical Advancements in 2024: A Leap Forward for Women’s Health

Institut Curie implements Versius surgical robotic system as part of research partnership

by

Institut Curie, said to be France’s leading cancer research centre, has introduced CMR Surgical’s Versius Surgical Robotic System as part of a two-year clinical study partnership.

The Versius system will initially be dedicated to gynaecological cancer surgery with a focus on minimally invasive hysterectomies.

Professor Steven Le Gouill, director of the Institut Curie Hospital Complex, says: “This technology enables our hospital to remain at the forefront of innovation. [Read more…] about Institut Curie implements Versius surgical robotic system as part of research partnership

Stäubli Robotics and Quantum Surgical partner to develop robotic platform for cancer surgery

by

Stäubli Robotics and Quantum Surgical, an innovative surgical robotic company, is developing an innovative solution, a combination of powerful software and robotic platform for minimally invasive therapies in liver cancer.

This strategic partnership aims to combine this “savoir-faire” to strengthen the role of robotics in minimally invasive cancer treatments and to build a “world leader”, according to the companies.

A memorandum of understanding has been signed by the two parties. [Read more…] about Stäubli Robotics and Quantum Surgical partner to develop robotic platform for cancer surgery

Kuka unveils robotics for modern treatment of tumors

by

A Munich therapy center uses a medical product with an integrated Kuka robot as a high-precision instrument in tumor treatment.

The CyberKnife system of Accuray, a kind of virtual knife, is an alternative to conventional radiotherapy.

Thanks to high-precision robot- and image-guided irradiation, the CyberKnife Center in Munich is able to treat tumors anywhere in the body – from the brain to the spinal column to various organs, such as the lungs, liver, kidneys or prostate. [Read more…] about Kuka unveils robotics for modern treatment of tumors

Stäubli Robotics and Quantum Surgical create ‘centre of excellence’ to develop oncology robotics

by

Stäubli Robotics and Quantum Surgical have launched a strategic partnership to create a centre of excellence in oncology robotics.

The alliance aims to strengthen the role of robotics in minimally invasive cancer treatments and to use the combined expertise of each company to create a world leader in patient care.

Quantum Surgical, an innovative surgical robotic company, is developing an innovative solution, that combines powerful software and a robotic platform to offer minimally invasive therapies in liver cancer. [Read more…] about Stäubli Robotics and Quantum Surgical create ‘centre of excellence’ to develop oncology robotics

Broad cancer vaccine may be out of reach

by

vaccination

The high level of genetic diversity between individual tumors suggests that if it were to be developed, a broad cancer vaccine would be unlikely to work for more than 0.3 per cent of the population, according to new research published in the open access journal Genome Medicine.

Next generation sequencing has revealed a wealth of information on the genetic diversity of tumors, which in turn has led to research into individualised treatments for cancer based on the molecular characteristics of a patient’s tumor.

Cancer vaccines are one type of prospective treatment that involves turning the patient’s immune system against the tumor.

Dr Ryan Hartmaier, lead author from Foundation Medicine, USA, said: “A broad or semi-universal vaccine capable of targeting many different tumors would be seen by some as the ‘holy grail’ of cancer therapy as it wouldn’t involve the time or cost of individualising treatment.  [Read more…] about Broad cancer vaccine may be out of reach